Walgreens Boots Alliance sells AmerisourceBergen shares for $1B of proceeds
Walgreens Boots Alliance has sold shares of AmerisourceBergen common stock pursuant to Rule 144 for proceeds of approximately $.8 billion and, subject to the completion of the Rule 144 sale, a concurrent share repurchase by AmerisourceBergen for proceeds of approximately $.2 billion.
Walgreens Boots Alliance’s ownership of AmerisourceBergen’s common stock decreased from approximately 20% to 17%.
Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown and the funding of the company’s strategic priorities, including the definitive agreement for VillageMD to acquire Summit Health-CityMD, the company said.
[Read more: Walgreens Boots Alliance reports Q4, fiscal 2022 results]
In addition, WBA stated that the sale has no impact on the long-term partnership between the two companies and that it remains fully committed to the strategic, mutually beneficial relationship with AmerisourceBergen, which has been a partner since 2013.
Additionally, the company noted that the chief operating officer of international for Walgreens Boots Alliance, Ornella Barra, will continue to serve on AmerisourceBergen’s board of directors.